Stentless tricuspid valve replacement.
Stentless tricuspid valve replacement was performed in a 21-year-old patient with severe destructive tricuspid valve endocarditis resistant to medical therapy. Postoperative recovery was uneventful. Stentless atrioventricular valves are considered an additional treatment option besides stented valves or homograft implantations for severe right-sided endocarditis. Transvalvular hemodynamics are excellent, and right ventricular function can be preserved by suspending the valve at the papillary muscles.
Walther
T
T
Department of Cardiac Surgery, Heart Center, University of Leipzig, Germany. walt@medizin.uni-leipzig.de
Falk
V
V
Schneider
J
J
Walther
C
C
Mohr
F W
FW
D000328:Adult; D001705:Bioprosthesis; D004697:Endocarditis, Bacterial / Q000601:surgery*; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D010210:Papillary Muscles / Q000601:surgery; D011474:Prosthesis Design; D013290:Streptococcal Infections / Q000601:surgery*; D014262:Tricuspid Valve Insufficiency / Q000601:surgery*